Aligos Therapeutics Inc (ALGS)
6.82
-3.75%
Aligos Therapeutics Inc (ALGS) is currently trading at $6.82. This represents a loss of 3.75% from the previous session. With a market capitalization of $0.04B, ALGS is a key component of the Health Care sector. Investors looking to trade ALGS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ALGS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Aligos Therapeutics Inc (ALGS) shows a bearish trend. Analysts are watching the 7.10 level closely.
Fundamentals
Mkt Cap0.04B
P/E Ratio0.0000
Volume21,880
60-Day Technical Chart
Advanced Charting
Need more indicators for ALGS? Use the world's #1 platform.
Open ALGS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $7
| Metric |
ALGS -3.75% |
ACHR +1.04% |
LUMN -1.14% |
QS +0.28% |
|---|---|---|---|---|
| Price | $6.82 | $7.27 | $7.37 | $7.06 |
| Mkt Cap | $0.04B | $4.74B | $7.52B | $4.23B |
| - | View → | View → | View → |
Latest Headlines
Aligos Therapeutics, Inc. Reports Positive Data from CROI Presentations on Pevifoscorvir Sodium and ALG-097558
Quiver Quantitative • Feb 23, 2026
Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely
Yahoo Finance • Jul 31, 2025
Aligos (NASDAQ: ALGS) grants 23,600-share inducement options under Nasdaq Rule 5635(c)(4)
Stock Titan • Nov 14, 2025
Wall Street Analysts Predict a 983.24% Upside in Aligos Therapeutics (ALGS): Here's What You Should Know
Nasdaq • Aug 19, 2025
Aligos Therapeutics stock rises on Phase 2 HBV study progress
Investing.com • Jan 21, 2026
● Gemini Agentic AI Analyst Insight for ALGS
Market Education
- Fed talking about Phillips Curve - I want to know what it is and how it impacts the interest rate Jul 18, 2023
- Trump’s Latest Tariffs Send Shockwaves Across U.S. Economy Sep 26, 2025
- Finding Stocks in the Squeeze Zone: Using Finviz Jun 2, 2024
External Research